Fortive delivers exceptional free cash flow conversion at 175% of net income and has recovered to two consecutive earnings beats, but technical momentum has weakened — with on-balance volume in a declining trend — and the stock sits just 3.1% below its near-term resistance target with an unfavorable risk/reward, warranting a hold-and-wait posture.
Thesis pillars
- Exceptional Cash Flow Quality→Stable
- Improving Earnings Execution↑Improving
- Weakening Technical Momentum↑Improving
- +1 more pillar — see the Why tab for full reasoning
Fortive Corporation (FTV) Stock Analysis
Technology · Scientific & Technical Instruments
Wait for pullback to $58.42. Weak momentum — blocks BUY_NOW at $58.48. Engine's entry $58.42 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Supplier: single supplier components; Analyst target reached - limited upside remaining.
Fortive Corporation designs and markets professional instruments, software, and services through two segments: Intelligent Operating Solutions (FLUKE, ACCRUENT, GORDIAN brands) and Advanced Healthcare Solutions (ASP, LANDAUER, PROVATION brands), employing over 10,000 people... Read more
Wait for pullback to $58.42. Weak momentum — blocks BUY_NOW at $58.48. Engine's entry $58.42 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Supplier: single supplier components; Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Score 6.1/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news boost analyst 0.50, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
About Fortive Corporation
About Fortive Corporation
Fortive Corporation restructured its portfolio on June 28, 2025 by separating its Precision Technologies segment as Ralliant Corporation, a tax-free spin-off, focusing the company on two segments: Intelligent Operating Solutions and Advanced Healthcare Solutions, with a workforce of over 10,000 professionals in approximately 50 countries. Intelligent Operating Solutions brands include FLUKE, SERVICECHANNEL, GORDIAN, ACCRUENT, and INDUSTRIAL SCIENTIFIC; Advanced Healthcare Solutions brands include ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION.
Fortive earns revenue through sales of instruments, software, and services to tens of thousands of industrial and healthcare customers. Intelligent Operating Solutions supplies test and measurement tools, facility and asset lifecycle software, and connected worker safety solutions to electrical engineers, facility managers, EHS professionals, and maintenance technicians across manufacturing, utilities, and communications industries. Advanced Healthcare Solutions addresses sterilization, biomedical testing, radiation dosimetry, and clinical documentation needs for hospital and surgical center operators. The company sells through direct and distributor channels; government entities represent a portion of each segment's revenue under agreements subject to statutes that apply to companies doing business with governments. Some specialty components depend on single or limited suppliers, though no single raw material supplier is described as material in aggregate. Fortive competes across highly fragmented markets against both multinational suppliers and regional specialists.
Show full overview
The Advanced Healthcare Solutions segment produces medical devices regulated by the U.S. FDA under the Federal Food, Drug and Cosmetic Act, with modifications to cleared devices potentially requiring new 510(k) filings and associated FDA user fees. Products for the European Economic Area must conform to the Medical Devices Regulation effective May 26, 2021, with a CE certificate from a notified body required before market access; the UK separately requires a UKCA Certificate. This multi-jurisdictional framework subjects AHS manufacturing facilities to routine FDA inspection and comparable foreign authority audits throughout the product lifecycle, and may result in ongoing compliance costs as requirements evolve.
See also: Technology · Scientific & Technical Instruments
From Fortive Corporation's most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated 2026-07-30Recent Developments — Fortive Corporation
Latest news
- NEWS Fortive (NYSE:FTV) Shares Down 9.1% - Here's What Happened - MarketBeat — MarketBeat negative
- NEWS FTV Q2 Earnings Beat on Core Growth, Guidance Raised - TradingView — TradingView positive
- NEWS FTV Q2 Earnings Beat on Core Growth, Guidance Raised - tradingview.com — tradingview.com positive
- NEWS Compared to Estimates, Fortive (FTV) Q2 Earnings: A Look at Key Metrics - Yahoo Finance — Yahoo Finance neutral
- NEWS Fortive’s (NYSE:FTV) Q2 CY2026: Beats On Revenue - StockStory — StockStory positive
Generated 2026-07-30T23:53:34Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSuppliersingle supplier components10-K Item 1: 'some components that require particular specifications or qualifications are dependent on a single supplier or a limited number of suppliers that can readily provide such components'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $58.42. Weak momentum — blocks BUY_NOW at $58.48. Engine's entry $58.42 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Supplier: single supplier components; Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Target $63.27 (+8.2%), stop $55.76 (−4.9%), A.R:R -0.7:1. Score 6.1/10, moderate confidence.
Take-profit target: $63.27 (-4.4% upside). Target $63.27 (+8.2%), stop $55.76 (−4.9%), A.R:R -0.7:1. Stop-loss: $55.76.
Concentration risk — Supplier: single supplier components; Analyst target reached - limited upside remaining; Negative momentum.
Fortive Corporation trades at a P/E of 35.0 (forward 18.5). TrendMatrix value score: 5.7/10. Verdict: Buy (Wait for Entry).
21 analysts cover FTV with a consensus score of 3.4/5. Average price target: $64.
What does Fortive Corporation do?Fortive Corporation designs and markets professional instruments, software, and services through two segments:...
Fortive Corporation designs and markets professional instruments, software, and services through two segments: Intelligent Operating Solutions (FLUKE, ACCRUENT, GORDIAN brands) and Advanced Healthcare Solutions (ASP, LANDAUER, PROVATION brands), employing over 10,000 people across approximately 50 countries. After spinning off its Precision Technologies segment as Ralliant in June 2025, the company focuses on safety and productivity tools and clinical workflow solutions sold to industrial, healthcare, and government customers.